TWST:NASDAQ
Twist Bioscience Corp
$179.49
arrow_downward
-1.83%(-3.34) 1D
Sep 28, 3:38:40 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$181.82
High
$187.86
Low
$175.02
Mkt. cap
11.88B
Avg. vol.
1.89M
Volume
1.58M
52-wk high
$187.86
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
Open
$181.82
High
$187.86
Low
$175.02
Mkt. cap
11.88B
Avg. vol.
1.89M
Volume
1.58M
52-wk high
$187.86
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
Investing.com UK
·
3 hours ago
Form 144 Twist Bioscience Corp For: 28 September By Investing.com
Seeking Alpha
·
5 hours ago
Twist Bioscience: Don't Confuse A Short Squeeze With An AI Revolution (NASDAQ:TWST)
Investing.com
·
1 day ago
Twist Bioscience SVP Dennis Cho sells $57,590 in company stock
Investing.com
·
1 day ago
Twist Bioscience SVP Paula Green sells $48,654 in common stock
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp